Carl Zeiss Meditec AG (OTCMKTS:CZMWY – Get Free Report) was the target of a large drop in short interest during the month of February. As of February 15th, there was short interest totalling 2,000 shares, a drop of 53.5% from the January 31st total of 4,300 shares. Based on an average daily volume of 10,600 shares, the short-interest ratio is presently 0.2 days.
Carl Zeiss Meditec Stock Performance
Shares of CZMWY stock traded up $0.84 during trading hours on Monday, hitting $62.18. 34,563 shares of the company were exchanged, compared to its average volume of 9,661. The company has a 50 day simple moving average of $54.28 and a two-hundred day simple moving average of $61.38. Carl Zeiss Meditec has a fifty-two week low of $46.13 and a fifty-two week high of $134.60.
Carl Zeiss Meditec Dividend Announcement
The business also recently disclosed an annual dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Friday, March 28th will be issued a dividend of $0.6246 per share. This represents a yield of 1%. The ex-dividend date is Friday, March 28th. Carl Zeiss Meditec’s dividend payout ratio is currently 32.64%.
Carl Zeiss Meditec Company Profile
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders.
Further Reading
- Five stocks we like better than Carl Zeiss Meditec
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- 3M to Hit $175 by Mid-Year, and Higher Highs Are Likely
- What is the FTSE 100 index?
- 4 Blockchain Stocks That Aren’t Coinbase
- Buy P&G Now, Before It Sets A New All-Time High
- These 3 Tech Stocks Are Gaining Steam After NVIDIA’s Report
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.